Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ifosfamide: a clinical review.

D Higgs, C Nagy, L H Einhorn

    Seminars in Oncology Nursing
    |May 1, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Ifosfamide, an alkylating agent, shows significant efficacy in refractory solid tumors like germ cell tumors and sarcomas. Its use is expanding due to reduced side effects and lack of cross-resistance with cyclophosphamide.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Frimley Faucet - an innovation in design of water-dispensing units in healthcare.

    Infection prevention in practice·2026
    Same author

    Polymicrobial outbreak of carbapenemase producing Enterobacterales managed using universal admission and discharge screening and water-safe built environment.

    The Journal of hospital infection·2024
    Same author

    Management of periprosthetic joint infection of the shoulder: A narrative review.

    Journal of clinical orthopaedics and trauma·2024
    Same author

    Comparison of methods for sampling and detection of carbapenemase-producing organisms in clinical handwash basin drains in health care.

    The Journal of hospital infection·2024
    Same author

    Assessment of mould remediation in a healthcare setting following extensive flooding.

    The Journal of hospital infection·2024
    Same author

    Comparative study on the deamidation of three recombinant human insulins using capillary electrophoresis.

    Journal of chromatography. A·2023

    Area of Science:

    • Oncology
    • Pharmacology

    Background:

    • Ifosfamide has been underutilized in American oncology despite earlier clinical trials.
    • Concerns regarding hemorrhagic cystitis have been addressed by urothelial protectors like mesna.
    • Ifosfamide exhibits distinct activity compared to cyclophosphamide, with no complete cross-resistance.

    Purpose of the Study:

    • To highlight the clinical significance and expanding role of ifosfamide in cancer treatment.
    • To emphasize ifosfamide's efficacy in refractory solid tumors.
    • To discuss ifosfamide's advantages over cyclophosphamide in combination chemotherapy.

    Main Methods:

    • Review of clinical trials and therapeutic applications of ifosfamide.
    • Comparison of ifosfamide's efficacy and toxicity profile with cyclophosphamide.

    Related Experiment Videos

  • Analysis of ifosfamide's role in treating specific refractory solid tumors.

    • Main Results:

    • Ifosfamide demonstrates significant activity in refractory germ cell tumors, soft tissue sarcomas, and malignant lymphomas.
    • Reduced myelosuppression and lack of cross-resistance make ifosfamide a valuable chemotherapeutic agent.
    • Ifosfamide is a key component in salvage regimens for refractory germ cell tumors.

    Conclusions:

    • Ifosfamide is an effective agent for various refractory solid tumors, particularly germ cell tumors.
    • Mitigation of side effects and distinct efficacy suggest ifosfamide may replace cyclophosphamide in some regimens.
    • Ifosfamide is integral to curative salvage therapy for refractory germ cell tumors.